메뉴 건너뛰기




Volumn 31, Issue 3, 2008, Pages 220-229

Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia™) for the prevention of emesis and motion sickness in cats

Author keywords

[No Author keywords available]

Indexed keywords

MAROPITANT; NEUROKININ 1 RECEPTOR ANTAGONIST; XYLAZINE;

EID: 43549084998     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00952.x     Document Type: Article
Times cited : (97)

References (27)
  • 1
    • 0027165533 scopus 로고
    • Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret
    • Andrew, P.L.R. Bhandari, P. (1993) Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology, 32, 799 806.
    • (1993) Neuropharmacology , vol.32 , pp. 799-806
    • Andrew, P.L.R.1    Bhandari, P.2
  • 5
    • 8044242890 scopus 로고
    • Resinferatoxin: A braod spectrum anti-emetic in the ferret
    • In. Eds. Bianchi, A.L., Grelot, L., Miller, A.D. King, G.L., pp. INSERM/John Libbey Eurotext, Montrouge.
    • Bhandari, P. Andrew, P.L.R. (1992) Resinferatoxin: a braod spectrum anti-emetic in the ferret. In Mechanisms and Control of Emesis. Eds Bianchi, A.L., Grelot, L., Miller, A.D. King, G.L., pp. 239 240. INSERM/John Libbey Eurotext, Montrouge.
    • (1992) Mechanisms and Control of Emesis. , pp. 239-240
    • Bhandari, P.1    Andrew, P.L.R.2
  • 7
    • 0345146337 scopus 로고
    • The central nervous connections involved in motion induced emesis
    • In. Ed. Crampton, G.H., pp. CRC Press, Boca Raton, USA.
    • Brizzee, K.R. (1990) The central nervous connections involved in motion induced emesis. In Motion and Space Sickness. Ed. Crampton, G.H., pp. 9 28. CRC Press, Boca Raton, USA.
    • (1990) Motion and Space Sickness. , pp. 9-28
    • Brizzee, K.R.1
  • 10
    • 33846520494 scopus 로고    scopus 로고
    • Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs
    • De la Puente-Redondo, V.A., Tilt, N., Rowan, T.G. Clemence, R.G. (2007b) Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. American Journal of Veterinary Research, 68, 48 56.
    • (2007) American Journal of Veterinary Research , vol.68 , pp. 48-56
    • De La Puente-Redondo, V.A.1    Tilt, N.2    Rowan, T.G.3    Clemence, R.G.4
  • 13
    • 0036452132 scopus 로고    scopus 로고
    • Imaging substance P receptors (NK-1) in the living human brain using positron emission tomography
    • Hargreaves, R. (2002) Imaging substance P receptors (NK-1) in the living human brain using positron emission tomography. The Journal of Clinical Psychiatry, 63 (Suppl. 11 18 24.
    • (2002) The Journal of Clinical Psychiatry , vol.63 , Issue.11 , pp. 18-24
    • Hargreaves, R.1
  • 14
    • 0024478025 scopus 로고
    • 3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat
    • 3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat. Pharmacology, Biochemistry and Behavior, 32, 207 210.
    • (1989) Pharmacology, Biochemistry and Behavior , vol.32 , pp. 207-210
    • Lucot, J.B.1
  • 16
    • 0029664892 scopus 로고    scopus 로고
    • Nonpeptide antagonists of the NK-1 tachykinin receptor
    • McLean, S. (1996) Nonpeptide antagonists of the NK-1 tachykinin receptor. Medicinal Research Reviews, 16, 297 317.
    • (1996) Medicinal Research Reviews , vol.16 , pp. 297-317
    • McLean, S.1
  • 17
    • 0027955353 scopus 로고
    • Emetic reflex are revealed by expression of the immediate-early gene c-fos in the cat
    • Miller, A.D. Ruggiero, D.A. (1994) Emetic reflex are revealed by expression of the immediate-early gene c-fos in the cat. Journal of Neuroscience, 14, 871 888.
    • (1994) Journal of Neuroscience , vol.14 , pp. 871-888
    • Miller, A.D.1    Ruggiero, D.A.2
  • 18
    • 0028276419 scopus 로고
    • Brain areas essential or non-essential for emesis
    • Miller, A.D., Nonaka, S. Jakus, J. (1994) Brain areas essential or non-essential for emesis. Brain Research, 647, 255 264.
    • (1994) Brain Research , vol.647 , pp. 255-264
    • Miller, A.D.1    Nonaka, S.2    Jakus, J.3
  • 19
    • 85047690901 scopus 로고    scopus 로고
    • Aprepitant - A novel NK-1-receptor antagonist
    • Patel, L. Lindley, C. (2003) Aprepitant - a novel NK-1-receptor antagonist. Expert Opinion Pharmacotherapy, 4, 2279 2296.
    • (2003) Expert Opinion Pharmacotherapy , vol.4 , pp. 2279-2296
    • Patel, L.1    Lindley, C.2
  • 21
    • 0033457351 scopus 로고    scopus 로고
    • Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK-1) antagonist
    • Rupniak, N.M. Kramer, M.S. (1999) Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK-1) antagonist. Trends in Pharmacological Sciences, 20, 485 490.
    • (1999) Trends in Pharmacological Sciences , vol.20 , pp. 485-490
    • Rupniak, N.M.1    Kramer, M.S.2
  • 22
    • 0032587925 scopus 로고    scopus 로고
    • The tachykinin NK-1 receptor in the brain: Pharmacology and putative functions
    • Saria, A. (1999) The tachykinin NK-1 receptor in the brain: pharmacology and putative functions. European Journal of Pharmacology, 375, 51 60.
    • (1999) European Journal of Pharmacology , vol.375 , pp. 51-60
    • Saria, A.1
  • 23
    • 30144444390 scopus 로고    scopus 로고
    • Kahn, C.M. (. ed. pp. 1047. Merck Publishing Group, Rahway, NJ.
    • Kahn, C.M. (ed. 2005) The Merck Veterinary Manual, 9th edn, pp. 1047. Merck Publishing Group, Rahway, NJ.
    • (2005) The Merck Veterinary Manual, 9th Edn
  • 25
    • 84944496221 scopus 로고
    • An unidentified depressor substance in certain tissue extracts
    • Von Euler, U.S. Gaddum, J.H. (1931) An unidentified depressor substance in certain tissue extracts. Journal of Physiology, 72, 74 87.
    • (1931) Journal of Physiology , vol.72 , pp. 74-87
    • Von Euler, U.S.1    Gaddum, J.H.2
  • 27
    • 34250688640 scopus 로고    scopus 로고
    • Vertigo and motion sickness. Part ll: Pharmacologic treatment
    • Zajonc, T.P. Roland, P.S. (2006) Vertigo and motion sickness. Part ll: pharmacologic treatment. Ear Nose and Throat, 85, 25 35.
    • (2006) Ear Nose and Throat , vol.85 , pp. 25-35
    • Zajonc, T.P.1    Roland, P.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.